The objective of the University of Michigan Center for Gastrointestinal Research (UMCGR) Administrative Core is to provide overall guidance, coordination and leadership for the Center. UMCGR Administrative Core leadership is provided by Dr. Chung Owyang, Director, and Drs. Juanita Merchant and M. Bishr Omary, Associate Directors, in conjunction with an Operations Committee, an Internal Advisory Committee, and an External Advisory Committee. The Operations Committee is comprised of the Director, at least one of the Associate Directors, at least one Core Director and other Center Investigators selected to serve three year renewable terms. The Operations Committee meets monthly and assists the Director in establishing the policies and plans of the Center and in reviewing the operations of the Center. On a yearly basis it reviews and approves all budgetary allocations as well as final allocations for Pilot/Feasibility Awards. The Internal Advisory Committee meets in formal sessions every year to review the operations and accomplishments of the Center and to provide counsel in areas of policy, administration, management and facilitates communication with institutional leaders to ensure that the Center remains responsive to overall institutional needs. The External Advisory Committee consists of five internationally prominent investigators who are leaders in digestive disease research and meets annually in person and by conference call as needed to provide regular feedback to the Executive Committee. An Administrator and Administrative Assistant provide the necessary support for real-time financial management and operations of the Center. The Executive Committee consists of the Director, both of the Associate Directors, the Administrator and Administrative Assistant and meets quarterly to plan and manage the UMCGR operations. The administrative leadership assures responsiveness of the UMCGR Cores to the needs of the Research Base and provides oversight for Core functions. UMCGR's many goals include the promotion of cutting edge digestive disease related research by: i) fostering collaborative, multidisciplinary research by expanding the technical and collaborative capabilities of established GI scientists and by attracting investigators from other disciplines; ii) implementing a robust Scientific Enrichment Program that includes research-in-progress seminars, academic workshops, an annual research retreat, and a semi-monthly visiting faculty seminar program; iii) nurturing new GI investigators via a peer reviewed, widely publicized Pilot and Feasibility Program; and, iv) promoting synergistic interaction between the Michigan Institute for Clinical and Health Research (MICHR), which houses the NIH-sponsored Michigan Clinical and Translational Science Award (CTSA) and the Michigan Clinical Research Center (MCRU), the NIDDK funded Michigan Nutrition and Obesity Research Center (MNORC) and Michigan Diabetes Research Center (MDRC), and among other DDRCCs including the Midwest DDRCC Alliance.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK034933-34
Application #
9978784
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2020-06-01
Budget End
2021-05-31
Support Year
34
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Wang, Xuexiang; Dande, Ranadheer R; Yu, Hao et al. (2018) TRPC5 Does Not Cause or Aggravate Glomerular Disease. J Am Soc Nephrol 29:409-415
Bhattacharya, Asmita; Sun, Shengyi; Wang, Heting et al. (2018) Hepatic Sel1L-Hrd1 ER-associated degradation (ERAD) manages FGF21 levels and systemic metabolism via CREBH. EMBO J 37:
Perry, Jeffrey W; Tai, Andrew W (2018) Random Insertional Mutagenesis of a Serotype 2 Dengue Virus Clone. Bio Protoc 8:
El-Zaatari, Mohamad; Bass, Adam J; Bowlby, Reanne et al. (2018) Indoleamine 2,3-Dioxygenase 1, Increased in Human Gastric Pre-Neoplasia, Promotes Inflammation and Metaplasia in Mice and Is Associated With Type II Hypersensitivity/Autoimmunity. Gastroenterology 154:140-153.e17
Sze, Marc A; Schloss, Patrick D (2018) Leveraging Existing 16S rRNA Gene Surveys To Identify Reproducible Biomarkers in Individuals with Colorectal Tumors. MBio 9:
Schofield, Heather K; Tandon, Manuj; Park, Min-Jung et al. (2018) Pancreatic HIF2? Stabilization Leads to Chronic Pancreatitis and Predisposes to Mucinous Cystic Neoplasm. Cell Mol Gastroenterol Hepatol 5:169-185.e2
Jiang, Lin; Su, Haoran; Keogh, Julia M et al. (2018) Neural deletion of Sh2b1 results in brain growth retardation and reactive aggression. FASEB J 32:1830-1840
Namkoong, Sim; Ho, Allison; Woo, Yu Mi et al. (2018) Systematic Characterization of Stress-Induced RNA Granulation. Mol Cell 70:175-187.e8
Han, Xu; Lee, Allen; Huang, Sha et al. (2018) Lactobacillus rhamnosus GG prevents epithelial barrier dysfunction induced by interferon-gamma and fecal supernatants from irritable bowel syndrome patients in human intestinal enteroids and colonoids. Gut Microbes :1-18
Hannigan, Geoffrey D; Duhaime, Melissa B; Koutra, Danai et al. (2018) Biogeography and environmental conditions shape bacteriophage-bacteria networks across the human microbiome. PLoS Comput Biol 14:e1006099

Showing the most recent 10 out of 757 publications